Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection
Conditions
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
seroma, axillary, dissection
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Intervention
Name: Glubran 2
Type: Device
Overall Status
Recruiting
Summary
Glubran 2 as a surgical glue maybe effective in reducing seroma formation post axillary dissection in breast cancer patients.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- The Patient should be above 18 years old

- The Patients has Node positive breast cancer

- The Patient is eligible for axillary dissection in addition to a surgical intervention for the primary tumor

- Patients whose sentinel lymph nodes test positive during surgery.

- The patient is willing to sign an informed consent to participation

Exclusion Criteria:

- Platelet count is less than 100000

- Obese patients with a BMI of more than 35

- Patients who need immediate breast reconstruction surgery

- Patients who are receiving anticoagulation therapy or have coagulation disorders

- Pregnant or lactating patients

- Patients who are on steroid therapy

- Patients who received chest radiotherapy

- Patients who received neoadjuvant chemotherapy
Location
King Hussein Cancer Center
Amman, Jordan
Status: Recruiting
Start Date
October 2013
Sponsors
King Hussein Cancer Center
Source
King Hussein Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page